Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …

Respiratory syncytial virus (RSV) is one of the most common respiratory viruses. It not only
affects young children but also the elderly and immunocompromised patients. After the …

Background The impact of SARS-CoV-2 alongside influenza is a major concern in the
northern hemisphere as winter approaches. Methods Test data for influenza and SARS-CoV …

Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may
complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The …

Given the current coronavirus disease 2019 (COVID-19) pandemic, coinfection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus (IAV) is a …

Background: The lack of specific vaccines or drugs against coronavirus disease 2019
(COVID-19) warrants studies focusing on alternative clinical approaches to reduce the …

The burden and impact of secondary superadded infections in critically ill coronavirus
disease 2019 (COVID‐19) patients is widely acknowledged. However, there is a dearth of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus (IAV)
represent two highly transmissible airborne pathogens with pandemic capabilities. Although …

Τhe COVID-19 pandemic highly impacted the circulation, seasonality, and morbidity burden
of several respiratory viruses. We reviewed published cases of SARS-CoV-2 and respiratory …

The most consequential challenge raised by coinfection is perhaps the inappropriate
generation of recombinant viruses through the exchange of genetic material among different …